Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Interest Coverage Ratio (2016 - 2026)

United Therapeutics' Interest Coverage Ratio history spans 17 years, with the latest figure at 115.06 for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 154.13% to 115.06 in Q4 2025 year-over-year; TTM through Dec 2025 was 76.54, a 138.45% increase, with the full-year FY2025 number at 76.54, up 138.45% from a year prior.
  • Interest Coverage Ratio hit 115.06 in Q4 2025 for United Therapeutics, down from 129.5 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for UTHR hit a ceiling of 129.5 in Q3 2025 and a floor of 14.09 in Q1 2021.
  • Historically, Interest Coverage Ratio has averaged 41.61 across 5 years, with a median of 34.07 in 2022.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 169.29% in 2021 and later surged 534.99% in 2022.
  • Tracing UTHR's Interest Coverage Ratio over 5 years: stood at 36.13 in 2021, then tumbled by 60.48% to 14.28 in 2022, then increased by 20.65% to 17.23 in 2023, then skyrocketed by 162.86% to 45.28 in 2024, then soared by 154.13% to 115.06 in 2025.
  • Business Quant data shows Interest Coverage Ratio for UTHR at 115.06 in Q4 2025, 129.5 in Q3 2025, and 49.93 in Q2 2025.